Longitudinal changes in Neuromelanin MRI Signal in Parkinson’s Disease
Objective: To examine the longitudinal changes in neuromelanin (NM) MRI signal in the substantia nigra (SN) in Parkinson’s disease (PD). Background: PD is characterized by…Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson’s Disease
Objective: We classified Parkinson’s disease (PD) patients into different subtypes and evaluated the correlation between the substantia nigra (SN) echogenicity and disease progression. Background: It…Transcranial imaging of substantia nigra hyperechogenicity in a Chinese cohort of Parkinson’s disease
Objective: In this research we set out to study the diagnostic value of TCS in Parkinson's disease. Background: An increased echogenicity of the substantia nigra…Ultrasonographic signatures associated with movement disorders (USA-MD study): A population-based longitudinal study
Objective: To identify sonographic biomarkers of PD (Parkinson´s disease). Background: Study of Parkinson’s disease biomarkers could lead us to identify the disease at its earlier…The effect of age on Substantia Nigra Hyperechogenicity in PD patients and healthy controls
Objective: To analyze whether the size of SN+ is differentially affected depending on disease start side. Secondly to analyze the interaction between a range of…Molecular Genetics and Functional Studies of LRRK2 Gene Variations in Parkinson’s Disease
Objective: To evaluate the function role of ROC domain in the brains of LRRK2 transgenic mice model and normal control mice. Background: Mutations in leucine-rich…Substantia nigra hyperechogenicity in male methamphetamine users
Objective: To investigate the effect of sex on substantia nigra (SN) echogenicity in young-to-middle aged adults with a history of methamphetamine use. Background: The sonographic…Evaluation of serum sestrin protein in Parkinson’s disease: a plausible diagnostic marker
Objective: In this study, we evaluated the concentrations of sesn1 and sesn2 in the serum of 50 PD patients and 60 elderly controls. Aging is…Cardiac 123I-MIBG Scintigraphy, olfactory testing and transcranial sonography for differentiating between Parkinson’s disease and atypical parkinsonian syndromes during the early stage
Objective: To evaluate the utility of the combined use of cardiac metaiodobenzylguanidine (MIBG) scintigraphy, olfactory testing, and substantia nigra (SN) hyperechogenicity on transcranial sonography (TCS)…A follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease and atypical parkinsonian syndrome
Objective: To evaluate whether the hyperechogenic size of the substantia nigra changes with time in Parkinson's disease (PD) and atypical parkinsonian syndromes (APSs), such as…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 11
- Next Page »